🟠 Moderate Evidence
L-theanine supplementation at doses between 200–450 mg daily consistently improves markers of sleep quality—including faster sleep onset and better sleep continuity—without causing next-day drowsiness or cognitive impairment, according to a systematic review published in Nutritional Neuroscience. The review analysed 13 randomised trials involving 550 participants aged 9–57 years, mostly adults, and found that the amino acid’s benefits were selective: it improved sleep efficiency and quality but did not significantly increase total sleep duration.
Key takeaways
- L-theanine at 200–450 mg/day shortened sleep latency and improved sleep continuity across 13 randomised trials (N=550)
- No clinically relevant next-day drowsiness, sedation, or cognitive impairment occurred, even at doses up to 900 mg/day for 8 weeks
- The supplement acts by increasing inhibitory neurotransmitters (GABA, acetylcholine) and may enhance alpha-wave activity, creating a relaxed pre-sleep state
- Evidence is strongest in healthy and subclinical populations; clinical insomnia populations remain understudied
Study at a Glance
| Source | Nutritional Neuroscience |
| Study type | Systematic Review of Randomised Controlled Trials |
| Number of trials | 13 randomised trials |
| Total participants | N = 550 (ages 9–57 years) |
| Dosing range | 50–900 mg/day (controlled trials: 200–450 mg/day) |
| Duration | Single-dose to 8 weeks |
L-Theanine’s Selective Effects on Sleep Parameters
Summary of outcomes across 13 randomised trials (N=550); improvement in quality metrics but not duration
Source: Nutritional Neuroscience Systematic Review | Georgian Medical Journal News
How L-Theanine Improves Sleep Without Sedation
L-theanine is a non-protein amino acid naturally present in green tea that works through distinct neurochemical mechanisms to promote sleep quality while maintaining daytime alertness. According to the Nutritional Neuroscience systematic review, L-theanine competes with glutamate at excitatory receptors—including the NMDA receptor—reducing excitatory signalling that would otherwise delay sleep onset. Simultaneously, the supplement increases concentrations of GABA (gamma-aminobutyric acid) and acetylcholine, neurotransmitters that enhance inhibitory tone and regulate REM sleep without causing general sedation.
The mechanism also includes enhancement of alpha-wave activity—the brain’s relaxed, wakeful state—which prepares the central nervous system for sleep onset without producing daytime drowsiness. In controlled trials cited within the review, L-theanine counteracted caffeine-induced sleep disruption, suggesting it may be particularly useful for individuals whose sleep is interrupted by afternoon or evening caffeine intake.
Safety Profile Across Dosing Ranges
The systematic review assessed safety data across a wide dosing spectrum—from 50 mg to 900 mg daily—and found that L-theanine was consistently safe and well-tolerated. No clinically relevant next-day drowsiness, sedation, or cognitive impairment occurred, even at high doses (400–900 mg/day) administered for up to 8 weeks. This safety profile contrasts sharply with prescription sleep aids, which frequently cause morning-after grogginess and cognitive dulling that can impair driving and occupational safety.
The absence of cognitive impairment is particularly important for shift workers, healthcare professionals, and others who require mental clarity after taking a sleep supplement. This distinguishes L-theanine from sedating antihistamines (e.g., diphenhydramine) and benzodiazepines, which are associated with residual impairment and dependence risk. For clinical updates on sleep medications, consult current guidelines from national regulatory bodies.
Across 13 randomised trials (N=550), L-theanine at 200–450 mg/day improved sleep latency, continuity, efficiency, and subjective sleep satisfaction without causing next-day drowsiness or cognitive impairment, even at doses up to 900 mg/day for 8 weeks.
— Nutritional Neuroscience Systematic Review (PMID: 41176609)
Current Evidence Gaps and Population Limitations
While the evidence base is robust for healthy and subclinical sleep populations, important gaps remain. Few of the 13 trials included participants with clinically diagnosed insomnia disorder, limiting the generalisability of findings to patients with primary or secondary insomnia. Additionally, some lower-dose trials (50–100 mg/day) showed limited efficacy, suggesting that dose optimisation is critical for therapeutic benefit.
Objective measures of sleep architecture—including polysomnography data on REM sleep, slow-wave sleep, and sleep-stage progression—remain understudied in the current literature. Most trials relied on participant-reported sleep quality (subjective outcomes) and actigraphy (wrist-worn motion tracking), which provide useful but incomplete information compared to gold-standard laboratory sleep studies. The review suggests that future research should prioritise controlled trials in insomnia populations and incorporate comprehensive objective sleep metrics.
What this means
Frequently asked questions
Is L-theanine the same as L-glutamine?
No. L-theanine and L-glutamine are distinct amino acids with different structures and functions. L-theanine is found primarily in tea leaves and acts on sleep and relaxation; L-glutamine is a standard amino acid involved in protein synthesis and gut health. L-theanine is the correct supplement for sleep optimisation.
Can I take L-theanine with prescription sleep medications?
Potentially, but only under medical supervision. L-theanine’s GABA-enhancing properties may have additive effects with benzodiazepines or barbiturates. If you are taking any prescription hypnotic or sedating medication, discuss L-theanine use with your doctor or pharmacist before starting.
How long does L-theanine take to work?
According to the systematic review, single-dose studies showed benefits within a dose cycle, though most controlled trials lasted 2–8 weeks. Peak effects may require consistent nightly use over 1–2 weeks. Onset within 30–60 minutes of ingestion is common, but individual variation exists.
As sleep disorders remain a leading cause of morbidity and healthcare utilisation in developed nations, supplements with favourable safety profiles warrant continued investigation. The current evidence supports L-theanine as a promising, non-habit-forming option for improving sleep quality in healthy populations, though rigorous trials in clinical insomnia cohorts and standardised dosing guidance remain priorities for future research and clinical practice.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
